Taraneh Mousavicover image
Taraneh Mousaviavatar

Taraneh Mousavi

A motivated pharmacist graduated from Tehran University of Medical Sciences (TUMS) who is highly expert in clinical research and scientific writing from narrative reviews to network meta-analyses. As a skilled pharmacist, I have gained deep experience in various aspects of the health care system, including community and hospital pharmacy, medication reconciliation, as well as drug and poison information center (DPIC). My main research interest is Pharmacoepidemiology, patient safety, evidence synthesis, systematic reviews and meta-analyses, and real-world effectiveness studies. Teamwork, problem-solving ,creativity, time-management and firm leadership are among the skills which have made me be successful in previous positions and responsibilities.
Living in : Iran
Gender : FemaleRace : White
Academic Profile
Posts

Contact Information

-Email
logo
TaranehMousaviApplyChance Link

Educations

Tehran University of Medical Sciences logo
PharmacyMaster'sTehran University of Medical Sciences2023-03-05 Iran
Supervisor's name :Mohammad Abdollahi

Work Experiences

Research Assistant
at TUMS
I am currently working in this role
Medication Consultant
at DPIC
I am currently working in this role
Hospital Pharmacist
at Sina Hospital
I am currently working in this role
Community Pharmacist
at 13-Aban TUMS Chain Pharma
I am currently working in this role
QPPV
at Arena Life Sci Co
I am currently working in this role

English Scores

TOEFL03-Jan-2023
107/120Total
Reading :
29/30
Listening :
29/30
Speaking :
23/30
Writing :
26/30

Conferences

Your Presentation Title :
Comparison of The Safety and Efficacy of Tofacitinib and Fingolimod in TNBS-Induced Colitis Model in Adult Zebrafish: The Role of Myd88/NF-κB/TNF-α Signaling Pathway
Conference Name :The Experimental Biology (EB)
United States of America (USA)
2022
Your Presentation Title :
A Comparison Between Efficacy and Safety of Two Small Molecules in Experimental Model of Ulcerative Colitis: A Hope for Future Clinical Translation
Conference Name :SOT 61th meeting
United States of America (USA)
2022

Journal Publications

Publication Title :
An Update on The Use of Pharmacotherapy for Opioid-Induced Bowel DysfunctionFirst author
Journal :
Expert Opinion on Pharmacotherapy
Link :
Publication Title :
Polychlorinated biphenyls: A review of recent updates on food safety and environmental monitoring, health and toxicological implications, and analysisCorresponding author
Journal :
Mini-Reviews in Medicinal Chemistry
Link :
Publication Title :
Combination Therapy of Cisplatin and Resveratrol to Induce Cellular Aging in Gastric Cancer Cells: Focusing on Oxidative stress, and Cell Cycle ArrestThird author
Journal :
Frontiers in Pharmacology
Link :
Publication Title :
Comparison of the safety and efficacy of fingolimod and tofacitinib in the zebrafish model of colitisFirst author
Journal :
Food and Chemical Toxicology
Link :
Publication Title :
A Comparison Between SARS-Cov-1 And SARS-Cov2: An Update on Current COVID19 VaccineCorresponding author
Journal :
DARU, Journal of Pharmaceutical Sciences
Link :
Publication Title :
Modification Of the Hemodynamic and Molecular Features of Phosphine, A Potent Mitochondrial Toxicant in The Heart, By CannabidiolCorresponding author
Journal :
Toxicology Mechanisms and Methods
Link :
Publication Title :
Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug RepurposingCorresponding author
Journal :
International Journal of Molecular Sciences
Link :
Publication Title :
Comparison of the Safety and Efficacy of Tofacitinib and Fingolimod in TNBS‐Induced Colitis Model in Adult Zebrafish: The Role of Myd88/NF‐κB/TNF‐α Signaling PathwayFirst author
Journal :
FASEB Journal
Link :
Publication Title :
The Pharmacotherapeutic Management of Duodenal and Gastric UlcersFirst author
Journal :
Expert Opinion on Pharmacotherapy
Link :
Publication Title :
A Novel Approach to Design Electrochemical Aptamer-Based Biosensor for Ultrasensitive Detecting of Zearalenone as A Prevalent Estrogenic Mycotoxin. Current Medicinal ChemistryCorresponding author
Journal :
Current Medicinal Chemistry
Link :
Publication Title :
Drug Repurposing for the Management of Depression: Where Do We Stand Currently?Third author
Journal :
Cellular and Molecular Life Sciences
Link :
Publication Title :
Comprehensive Study on The Administrative, Economic, Regional, And Regulatory Prospects of Complementary and Alternative Medicine (CAM) in Inflammatory Bowel Disease (IBD)First author
Journal :
Expert Review of Clinical Pharmacology
Link :
Publication Title :
Achieving Equitable Access to Medicines and Health Services: a COVID-19-time Recalled MatterFirst author
Journal :
Iranian Journal of Pharmaceutical Research
Link :
Publication Title :
Drug Discovery Strategies for Modulating Oxidative Stress in Gastrointestinal DisordersFirst author
Journal :
Expert Opinion on Drug Discovery
Link :
Publication Title :
An Update on Efficacy and Safety Considerations for The Latest Drugs Used to Treat Irritable Bowel SyndromeFirst author
Journal :
Expert Opinion on Drug Metabolism and Toxicology
Link :
Publication Title :
A Review of The Current Concerns About Misconduct in Medical Sciences Publications and The ConsequencesFirst author
Journal :
DARU, Journal of Pharmaceutical Sciences
Link :

Research Keywords

Patient Safety
public health
Pharmacoepidemiology
real-world data
evidence synthesis

Awards

First Rank Student in UniversityMaster
Proposal GrantElite Research2019-12-24

References

Mohammad Abdollahi
Mohammad@tums.ac.ir
Shekoufeh Nikfar
Nikfar_sh@tums.ac.ir